These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21656687)

  • 1. Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer.
    Soon WW; Miller LD; Black MA; Dalmasso C; Chan XB; Pang B; Ong CW; Salto-Tellez M; Desai KV; Liu ET
    EMBO Mol Med; 2011 Aug; 3(8):451-64. PubMed ID: 21656687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of serine protease inhibitor kazal type 1 predicts poor prognosis and promotes the progression and invasion of oral tongue squamous cell carcinoma.
    Wang S; Sun Y; Shao D; Pan Y; Gao X; Zhao P; Liu Q; Shang G; Shang W; Fu Z; Sun Y
    Arch Oral Biol; 2024 Aug; 164():106003. PubMed ID: 38781741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Roles of SPINK1 in Cancer.
    Räsänen K; Itkonen O; Koistinen H; Stenman UH
    Clin Chem; 2016 Mar; 62(3):449-57. PubMed ID: 26656134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic targeting of SPINK1-positive prostate cancer.
    Ateeq B; Tomlins SA; Laxman B; Asangani IA; Cao Q; Cao X; Li Y; Wang X; Feng FY; Pienta KJ; Varambally S; Chinnaiyan AM
    Sci Transl Med; 2011 Mar; 3(72):72ra17. PubMed ID: 21368222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FSIP1 is correlated with estrogen receptor status and poor prognosis.
    Li X; Song X; Ma J; Zhao Y; Jiang Q; Zhao Z; Li M
    Mol Carcinog; 2020 Jan; 59(1):126-135. PubMed ID: 31713931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serine protease inhibitor Kazal type 1 (SPINK1) promotes proliferation, migration, invasion and radiation resistance in rectal cancer patients receiving concurrent chemoradiotherapy: a potential target for precision medicine.
    Chen YT; Tseng TT; Tsai HP; Kuo SH; Huang MY; Wang JY; Chai CY
    Hum Cell; 2022 Nov; 35(6):1912-1927. PubMed ID: 36053457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of serine protease inhibitor Kazal type 1 (SPINK1) in pancreatic diseases.
    Ohmuraya M; Yamamura K
    Exp Anim; 2011; 60(5):433-44. PubMed ID: 22041280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6 increases expression of serine protease inhibitor Kazal type 1 through STAT3 in colorectal adenocarcinoma.
    Räsänen K; Lehtinen E; Nokelainen K; Kuopio T; Hautala L; Itkonen O; Stenman UH; Koistinen H
    Mol Carcinog; 2016 Dec; 55(12):2010-2023. PubMed ID: 26663388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serine Protease Inhibitor Kazal Type 1 (SPINK1) Promotes Proliferation of Colorectal Cancer Through the Epidermal Growth Factor as a Prognostic Marker.
    Chen YT; Tsao SC; Yuan SS; Tsai HP; Chai CY
    Pathol Oncol Res; 2015 Sep; 21(4):1201-8. PubMed ID: 26037168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine protease inhibitor Kazal type 1 (SPINK1) downregulates E-cadherin and induces EMT of hepatoma cells to promote hepatocellular carcinoma metastasis via the MEK/ERK signaling pathway.
    Ying HY; Gong CJ; Feng Y; Jing DD; Lu LG
    J Dig Dis; 2017 Jun; 18(6):349-358. PubMed ID: 28544403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
    Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
    J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine protease inhibitor Kazal type 1 promotes proliferation of pancreatic cancer cells through the epidermal growth factor receptor.
    Ozaki N; Ohmuraya M; Hirota M; Ida S; Wang J; Takamori H; Higashiyama S; Baba H; Yamamura K
    Mol Cancer Res; 2009 Sep; 7(9):1572-81. PubMed ID: 19737965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer.
    Kurozumi S; Joseph C; Sonbul S; Aleskandarany MA; Pigera M; Alsaleem M; Alsaeed S; Kariri Y; Nolan CC; Diez-Rodriguez M; Johnston S; Mongan NP; Fujii T; Shirabe K; Martin SG; Ellis IO; Green AR; Rakha EA
    Breast Cancer Res Treat; 2018 Nov; 172(1):61-68. PubMed ID: 30056565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance.
    Chen F; Long Q; Fu D; Zhu D; Ji Y; Han L; Zhang B; Xu Q; Liu B; Li Y; Wu S; Yang C; Qian M; Xu J; Liu S; Cao L; Chin YE; Lam EW; Coppé JP; Sun Y
    Nat Commun; 2018 Oct; 9(1):4315. PubMed ID: 30333494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients.
    Brooks JD; Wei W; Hawley S; Auman H; Newcomb L; Boyer H; Fazli L; Simko J; Hurtado-Coll A; Troyer DA; Carroll PR; Gleave M; Lance R; Lin DW; Nelson PS; Thompson IM; True LD; Feng Z; McKenney JK
    PLoS One; 2015; 10(7):e0132343. PubMed ID: 26172920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers.
    Mehner C; Oberg AL; Kalli KR; Nassar A; Hockla A; Pendlebury D; Cichon MA; Goergen KM; Maurer MJ; Goode EL; Keeney GL; Jatoi A; Sahin-Tóth M; Copland JA; Radisky DC; Radisky ES
    Oncotarget; 2015 Nov; 6(34):35737-54. PubMed ID: 26437224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPINK1 promotes cell growth and metastasis of lung adenocarcinoma and acts as a novel prognostic biomarker.
    Xu L; Lu C; Huang Y; Zhou J; Wang X; Liu C; Chen J; Le H
    BMB Rep; 2018 Dec; 51(12):648-653. PubMed ID: 30545439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Roles of SPINK1 in Cancers.
    Lin TC
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33916984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAG-1 expression correlates with Bcl-2, p53, differentiation, estrogen and progesterone receptors in invasive breast carcinoma.
    Tang SC; Beck J; Murphy S; Chernenko G; Robb D; Watson P; Khalifa M
    Breast Cancer Res Treat; 2004 Apr; 84(3):203-13. PubMed ID: 15026618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of physiological stress conditions on protein structure and trypsin inhibition of serine protease inhibitor Kazal type 1 (SPINK1) and its N34S variant.
    Buchholz I; Nagel F; Klein A; Wagh PR; Mahajan UM; Greinacher A; Lerch MM; Mayerle J; Delcea M
    Biochim Biophys Acta Proteins Proteom; 2020 Jan; 1868(1):140281. PubMed ID: 31525466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.